Skip to main content
Retour
Watch Compare

Genprex, Inc.

Qualité des données : 83%
GNPX
Nasdaq Manufacturing Chemicals
1,15 €
▼ 0,15 € (-11,54%)
Cap. Boursière: 11,76 M
Prix
1,30 €
Cap. Boursière
11,76 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -15,31 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-1503,38%
En dessous de la moyenne du secteur (-53,41%)
ROIC-1020,59%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,67
Interest CoverageN/A

Valorisation

PE (TTM)
-0,72
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio15,31
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,7 -1,5
P/B 15,3 1,6
ROE % -1503,4 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -16,23 M
ROE -1503,38% ROA -439,21%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15,31 M
ROIC -1020,59% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,67
Interest Coverage N/A Asset Turnover N/A
Working Capital -836 605 Tangible Book Value 767 807
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,72 Forward P/E N/A
P/B Ratio 15,31 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -130,22%
Market Cap 11,76 M Enterprise Value 10,65 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -1,69 OCF / Share -1,69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 94,35%
SBC-Adj. FCF -15,92 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 0,0 0,0 0,0 0,0
Net Income -16,23 M -21,11 M -30,86 M -23,74 M -19,60 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -15,52 M -21,17 M -31,08 M -23,83 M -19,60 M
EBITDA — — — — —
R&D Expenses 9,43 M 10,54 M 17,62 M 11,51 M 8,61 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0,0 2 650,0 0,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,16 M 4,12 M 10,67 M 25,09 M 42,86 M
Total Liabilities 2,20 M — — 2,46 M —
Shareholders' Equity 7,96 M 1,62 M 7,42 M 22,27 M 41,28 M
Total Debt — — — — —
Cash & Equivalents 7,83 M 1,60 M 6,74 M — —
Current Assets 8,36 M 2,08 M 7,53 M 21,47 M 39,14 M
Current Liabilities 2,17 M 2,50 M 3,25 M 2,81 M 1,59 M